A trial production of a table of the optical crystallographic characteristics of crystalline drugs including crystal habits (study of crystalline drugs by means of a polarizing microscope. XIX)

Yakugaku Zasshi

Volumn 122, Issue 8, 2002, Pages 595-606

  Watanabe, Atsushi ^a  

^a Kenbikogaku Kenkyusho Ltd   (Japan)

Author keywords

Crystal habit predominant face; Key principal refractive index; Polarizing microscopy

Indexed keywords

2 NAPHTHOL; ACETARSOL; ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ALLOPURINOL; AMINOPHENAZONE; AMINOPHYLLINE; AMITRIPTYLINE; AMMONIUM CHLORIDE; AMOBARBITAL; ARECOLINE; ARSENIC TRIOXIDE; ASCORBIC ACID; ATROPINE; BENZETHONIUM CHLORIDE; BENZOCAINE; BENZOIC ACID; BENZTHIAZIDE; BETAMETHASONE; BIPERIDEN; BORIC ACID; BUSULFAN; BUTACAINE; BUTETHAL; CAFFEINE; CALCIUM PHOSPHATE DIBASIC; MERCUROUS CHLORIDE; PANTOTHENATE CALCIUM; PENICILLIN G POTASSIUM; UNINDEXED DRUG; DRUG;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; CRYSTALLOGRAPHY; DRUG STRUCTURE; POLARIZATION MICROSCOPE; QUALITATIVE ANALYSIS; REFRACTOMETRY; STRUCTURE ANALYSIS; CHEMISTRY; METHODOLOGY; POLARIZATION MICROSCOPY;

CRYSTALLIZATION; CRYSTALLOGRAPHY; MICROSCOPY, POLARIZATION; PHARMACEUTICAL PREPARATIONS;

EID: 0036674912     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.122.595     Document Type: Article

References (19)

1. Watanabe A., Ohnuma N., Yakugaku Zasshi, 120, 290-297, (2000).
2. Watanabe A., Yakugaku Zasshi, 59, 131-141, 30-32, (1939).
3. Watanabe A., Proceedings of the 8h Asian Congress of Pharmaceutical Sciences and the 9th General Assembly, Scientific Section, 1980, pp. 59-63.
4. "The Optical Crystallographic Data of NF Drugs Compiled by Eisenberg," National Formulary XIII, American Pharmaceutical Association, Washington, D.C., 1970, pp. 1041-1056.
5. Watanabe A., Yamaoka Y., Akaho E., Kuroda K., Yokoyama T., Umeda T., Chem. Pharm. Bull., 33, 1599-1608, (1985).
6. Kuroda K., Yokoyama T., Umeda T., Takagishi Y., Chem. Pharm. Bull., 26, 2565-2568, (1978).
7. Watanabe A., Yamaoka Y., Kuroda K., Yokoyama T., Umeda T., Yakugaku Zasshi, 105, 481-490, (1985).
8. Watanabe A., Ohnuma N., Yakugaku Zasshi, 113, 159-158, (1993).
9. Watanabe A., Tanaka Yu., Tanaka Yo., Chem. Pharm. Bull., 25, 2239-2243, (1977).
10. Watanabe A., Yamaoka Y., Takada K., Chem. Pharm. Bull., 30, 2958-2963, (1982).
11. Watanabe A., Yamaoka Y., Kuroda K., Yokoyama T., Yakugaku Zasshi, 104, 896-902, (1984).
12. Watanabe A., Yakugaku Zasshi, 106, 825-836, (1986).
13. Watanabe A., Yakugaku Zasshi, 58, 565-571, 145-149 (1938).
14. Watanabe A., Yakugaku Zasshi, 60, 416-419, 163-164 (1940).
15. Watanabe A., Ohnuma N., Yakugaku Zasshi, 114, 80-88, (1994).
16. Watanabe A., Ohnuma N., Yakugaku Zasshi, 116, 822-829, (1996).
17. Watanabe A., Naturwissenschaften 29, 116, (1941).
18. Watanabe A., Ohnuma N., Yakugaku Zasshi, 115, 329-343, (1995).
19. Watanabe A., Yakugaku Zasshi, 117, 771-785 (1997).